Editas Medicine
EDIT
116 hedge funds and large institutions have $698M invested in Editas Medicine in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 16 closing their positions.
50% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 16
42% more capital invested
Capital invested by funds: $490M → $698M (+$207M)
42% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 26
5% more funds holding
Funds holding: 110 → 116 (+6)
1.64% less ownership
Funds ownership: 70.65% → 69.01% (-1.6%)
30% less call options, than puts
Call options by funds: $6.76M | Put options by funds: $9.71M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$25M |
| 2 |
GTP
Global Thematic Partners
New York
|
+$10.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$6.31M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$5.94M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$5.14M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DTL
126
Dynamic Technology Lab
Singapore
| – | -$413K | -24,593 | Closed |
|
127
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$363K | -19,051 | Closed |
|
|
HTC
128
Hershey Trust Company
Hershey,
Pennsylvania
| – | -$244K | -14,545 | Closed |
|
|
AIMCA
129
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
| – | -$191K | -11,400 | Closed |
|
|
HHMI
130
Howard Hughes Medical Institute
Chevy Chase,
Maryland
| – | -$50K | -2,980 | Closed |
|
|
KF
131
Krilogy Financial
St. Louis,
Missouri
| – | -$3K | -200 | Closed |
|
|
MAM
132
Meeder Asset Management
Dublin,
Ohio
| – | -$2K | -128 | Closed |
|
EDIT Hedge Fund Activity: Q3 2017 in Review
116 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2017, worth a combined $698M — up 42% from $490M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new EDIT positions and 16 closed out — a net gain of 8 holders — while 37 added to existing stakes and 26 trimmed.
The largest buyer was State Street, adding an estimated $25M. The largest seller was Flagship Pioneering, cutting an estimated $32.4M.
- 116 institutional investors held Editas Medicine (EDIT) as of Q3 2017, up from 110 in Q2 2017.
- Funds reported $698M of Editas Medicine stock for Q3 2017, up 42% quarter-over-quarter.
- 24 funds opened new Editas Medicine positions in Q3 2017 and 16 closed out, a net change of +8 holders.
- The largest Editas Medicine buyer in Q3 2017 was State Street, an estimated $25M added.
- The largest Editas Medicine seller in Q3 2017 was Flagship Pioneering, an estimated $32.4M sold.
Based on aggregated 13F filings for Q3 2017.